Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,195 total articles
Valvoline Inc.'s Chief Financial Officer, J. Kevin Willis, recently purchased a significant block of company shares totaling $318,000. This insider activity occurred while the stock was experiencing a decline over the preceding week. The purchase follows recent positive operational and financial disclosures for the second quarter of 2026, where Val…
Valvoline Inc. director Richard Joseph Freeland recently increased his personal stake in the company by purchasing 3,100 shares of common stock on May 14, 2026. This transaction occurred as Valvoline's stock price had declined over the past week. The news arrives shortly after the company announced robust second-quarter financial results for 2026, …
Donegal Mutual Insurance Co., a significant shareholder in Donegal Group Inc., recently purchased a notable block of Class A common stock. Separately, the company held its annual meeting of shareholders, where key decisions regarding board governance were made and several directors were re-elected or newly elected for defined terms.
A director at USCB Financial Holdings sold a significant block of company stock in mid-May 2026. This transaction occurred against a backdrop of the firm reporting strong first-quarter results, with both earnings per share and revenue surpassing forecasts. Despite these positive financial outcomes, an analyst firm adjusted its price target downward…
Japan Post Holdings Co., Ltd., a major investor in Aflac Incorporated (NASDAQ:AFL), recently reported the sale of common stock. This transaction occurred alongside other corporate developments for AFLAC, including mixed first-quarter 2026 earnings results and significant shareholder actions regarding board appointments and operational expansions.
Harrow, Inc.'s Chief Executive Officer, Mark L. Baum, recently acquired a significant block of the company's common stock, totaling $302,000. This insider activity occurred shortly after HROW shares experienced a 19% decline over the previous week. Separately, Harrow Health Inc. released its first-quarter 2026 financial results, which indicated sho…
Harrow, Inc. (NASDAQ: HROW) President and CFO Andrew R. Boll acquired a significant block of the company's common stock on May 14, 2026. This buying activity occurred despite the stock experiencing notable declines year-to-date and over the past week. The news follows Harrow Health Inc.'s recent first quarter 2026 financial reporting, which reveale…
Cohu director William Bendush sold a substantial number of shares through an established 10b5-1 plan. This transaction occurs as the company reports strong forward guidance for revenue and sees multiple analysts raising their price targets due to increased demand in AI compute and high-performance computing.
Director Steven Kyle Boyd increased his personal investment in OraSure Technologies Inc. (OSUR) by acquiring 75,000 common shares over a span of three days in mid-May 2026. These open market purchases totaled $224,750. The activity occurred against the backdrop of recent company performance, as OSUR reported first-quarter results that fell short of…
The announcement of a stock sale by SiTime director Takata Akira provides an immediate data point regarding internal confidence. This transaction occurs against the backdrop of strong first-quarter financial results for SITIME Corp., which also highlights concerns surrounding the company's current valuation relative to market metrics.
John W. Kozarich, a director at Ligand Pharmaceuticals Inc., executed multiple sales totaling $563,079 worth of the company's common stock during the first half of May. This activity occurred against a backdrop of mixed market signals for LGND; while shares have seen an 112% gain over the last year and some analysts raised earnings forecasts, the c…
MarketWise, Inc. (MKTW) saw notable insider buying when director Frank Porter Stansberry acquired a total of 30,000 shares of Class A Common Stock over two weeks in May 2026. This activity occurred as the stock trades at $17.27, prompting analysis regarding its valuation relative to perceived fair value. Concurrently, the company released its fourt…
A report details a recent stock sale by a director at The Charles Schwab Corporation (SCHW), alongside significant corporate updates. Key findings include the director's sale of shares held through a trust, prior option acquisitions via nonqualified stock options, and broader company data showing increased client assets and new brokerage account op…
Director Bradley Lee Soultz executed multiple transactions selling common stock of WillScot Holdings Corp (WSC) totaling approximately $4,205,565 over the course of May 12 and May 13, 2026. These sales involved both shares held directly by Mr. Soultz and those managed through various trusts. The reported transactions occurred against a backdrop whe…
A director at Abundia Global Impact Group, Inc. recently purchased a substantial amount of the company's common stock. This transaction occurs amidst several significant corporate announcements regarding AGIG, including the scheduling of its 2026 annual stockholder meeting, the successful raising of $20 million from an institutional investor, and p…
Insider activity at Rocket Lab Corp has been reported, noting a substantial sale of common stock shares by director Alexander R. Slusky via an indirect holding structure. This report details the transaction amounts and prices relative to the company's current market performance. Furthermore, recent financial disclosures reveal robust first-quarter …
Innodata Inc. (NASDAQ:INOD) recently saw its CEO and director, Jack Abuhoff, execute substantial sales of common stock between May 12 and May 14, 2026. These transactions totaled approximately $22.8 million, representing a sale of 243,150 shares at prices ranging from $90.20 to $97.66 per share. This activity occurred while the company's stock had …
Protagonist Therapeutics' CEO, Dinesh V. Patel, executed a substantial sale of common stock valued at approximately $7.5 million on May 12, 2026. This transaction followed the exercise of vested stock options under a pre-arranged Rule 10b5-1 plan. The timing is notable as Protagonist Therapeutics (NASDAQ:PTGX) shares are trading near their 52-week …
Abhinav A. Shukla, Chief Technical Officer at Shattuck Labs, Inc., recently sold a block of company shares. This sale occurred against the backdrop of significant stock performance for Shattuck Labs (NASDAQ:STTK) over the past year and positive assessments regarding its drug candidate SL-325 from TD Cowen.
Andrew Bialecki, Co-Chief Executive Officer and director of Klaviyo, Inc. (NASDAQ:KVYO), recently reported a significant stock sale worth approximately $2.92 million on May 12, 2026. This transaction was executed through a prearranged Rule 10b5-1 trading plan. The report details Bialecki's holdings and provides context regarding the company's recen…
Chairman Sardar Biglari, through his associated funds, executed a significant purchase of Biglari Holdings Inc. (BH) Class B common stock between May 12 and May 14, 2026. The buying spree totaled over $13 million for 52,674 shares, occurring shortly after the stock experienced a notable decline. This insider activity takes place against a backdrop …
Multiple key stakeholders, including North Run Strategic Opportunities Fund I, LP, director Thomas B. Ellis, and member Todd B. Hammer, sold a total of 293,052 shares of LightPath Technologies' Class A Common Stock between May 12 and May 14, 2026, netting approximately $3.57 million. This selling activity occurs following substantial gains for the …
Recent SEC filings reveal that Maciej Kurzymski, Chief Accounting Officer of Bloom Energy Corp., engaged in notable stock transactions. The sale of over $1.8 million in Class A Common Stock occurred amidst strong market performance and subsequent analyst upgrades following the company's recent quarterly report.
Arundathy N. Pandite, Chief Medical Officer at Shattuck Labs, Inc., recently executed a sale of company stock through a prearranged trading plan. This transaction occurred amidst significant stock appreciation and positive developments regarding the company's lead drug candidate. Furthermore, TD Cowen has maintained a Buy rating for Shattuck Labs f…
James H. Litinsky, the chairman and CEO of MP Materials Corp., executed multiple sales totaling approximately $19.6 million worth of shares over two days in May 2026. These transactions occurred while the company's stock was trading below recent highs. Despite the insider selling activity, MP Materials recently reported strong first-quarter financi…
